Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry
ISSN: 0975-413X
Abstract
Development and validation of new RP-HPLC method for determining impurity profiling in olmesartan medoxomil drug as well as in tablet dosage form
Author(s): Nandini R Pai and Seema S. SawantA simple, rapid, sensitive, accurate, precise and reproducible high performance liquid chromatographic method was developed to estimate impurity profile for Olmesartan medoxomil in drug as well as in tablet dosage form. The HPLC analysis used a reversed phase Kromasil C18 (150 x 4.6mm, 5μm) column and a mobile phase constituted of buffer and acetonitrile (60:40 % v/v). The buffer was composed of 4.7 g of sodium dihydrogenorthophosphate and 1 mL of triethyl amine in 1000 mL of water and the pH of the solution was adjusted to 4.0± 0.05 with orthophosphoric acid. The wave length of the detection was 225 nm. The validation data showed that the method is sensitive, specific and reproducible for the impurity determination of olmesartan in the dosage form. The method was found to be linear from 2 μg/mL to 7 μg/mL for Olmesartan medoxomil and from 0.25 μg/mL to 7 μg/mL for olmesartan Acid Impurity. The accuracy of the method was found to be 100.73% for olmesartan acid impurity. Inter and intraday assay relative standard deviation (RSD) was less than 0.71% in drug form and 1.10% in tablet dosage form for Olmesartan acid impurity. The proposed method provided an accurate and precise analysis of Olmesartan acid impurity in Olmesartan medoxomil Drug form as well as in pharmaceutical dosage form
Select your language of interest to view the total content in your interested language
Google Scholar citation report
Citations : 15261
Der Pharma Chemica received 15261 citations as per Google Scholar report
Der Pharma Chemica peer review process verified at publons
